February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Discovering Complex Clinical and Pathological Features

Virtual 2021 International Conference on Alzheimer’s & Parkinson’s Diseases

Key Learning Objectives for Biogen’s ADPD 2021 Symposium:

  • Understand how mixed pathologies and varying clinical presentations can affect the early diagnosis of Alzheimer’s disease
  • Gain insights into how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an early diagnosis of Alzheimer’s disease in challenging cases with mixed pathologies
  • Assess the current healthcare system readiness for timely diagnosis of Alzheimer’s disease and management of patients

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.